Literature DB >> 19229669

Use of the labscale tangential flow diafiltrator to remove tetrameric hemoglobin from polyhemoglobin, purify hemolysate, and concentrate polyhemoglobin.

Ada Stefanescu1, Thomas Ming Swi Chang.   

Abstract

The Labscale tangential flow diafiltration system in conjunction with polyethersulfone Biomax filters (both purchased from Millipore Inc.) were used in the following studies: (1) A crucial step in the preparation of polyhemoglobin (polyHb) is the removal of tetrameric hemoglobin (Hb), which can cause adverse side-effects. The efficiency for this depends on the integrity of the 100kDa filters. Those with lower integrity were not effective whereas those with a higher integrity of 0.075ml/min were more effective. A filter with an integrity of 0.075ml/min can reduce the initial 11.2% tetrameric Hb concentration to 1.3% using a flow rate of 0.2ml/min. Higher flow rate of 2.2ml/min was not as effective. (2) Filtration with a 100kDa filter was quick and efficient in separating stroma-free hemoglobin solutions from cellular debris from hemolysate. (3) Both 5kDa and 100kDa filters are efficient in concentrating hemoglobin solutions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229669      PMCID: PMC3518471          DOI: 10.1080/10731190902742455

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  6 in total

1.  SEMIPERMEABLE MICROCAPSULES.

Authors:  T M CHANG
Journal:  Science       Date:  1964-10-23       Impact factor: 47.728

2.  Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram.

Authors:  Binglan Yu; Zunchang Liu; Thomas Ming Swi Chang
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2006

3.  Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.

Authors:  Thomas Ming Swi Chang
Journal:  Biochim Biophys Acta       Date:  2008-06-17

4.  Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde.

Authors:  T M Chang
Journal:  Biochem Biophys Res Commun       Date:  1971-09-17       Impact factor: 3.575

5.  The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable.

Authors:  Steven A Gould; Ernest E Moore; David B Hoyt; Paul M Ness; Edward J Norris; Jeffrey L Carson; George A Hides; Ian H G Freeman; Richard DeWoskin; Gerald S Moss
Journal:  J Am Coll Surg       Date:  2002-10       Impact factor: 6.113

6.  Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Authors:  Ernest E Moore; Frederick A Moore; Timothy C Fabian; Andrew C Bernard; Gerard J Fulda; David B Hoyt; Therese M Duane; Leonard J Weireter; Gerardo A Gomez; Mark D Cipolle; George H Rodman; Mark A Malangoni; George A Hides; Laurel A Omert; Steven A Gould
Journal:  J Am Coll Surg       Date:  2008-11-07       Impact factor: 6.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.